Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PSNL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
29 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 23 days ago
Red flags: 1
159 filers reported a long position in PSNL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Merck & Co., Inc. | $188.2M | 14M | Unchanged |
| ARK Investment Management LLC | $110.8M | 8.3M | +4.1% |
| BlackRock, Inc. | $94.9M | 7.1M | +31.4% |
| Lightspeed Management Company, L.L.C. | $81.8M | 6.1M | -25.2% |
| AMERIPRISE FINANCIAL INC | $81.6M | 6.1M | -19.8% |
| Deep Track Capital, LP | $53.6M | 4M | +33.3% |
| Aberdeen Group plc | $50.2M | 3.7M | +7.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.3M | 3M | +4.9% |
| Casdin Capital, LLC | $34.2M | 2.6M | +59.4% |
| KENNEDY CAPITAL MANAGEMENT LLC | $31.7M | 2.4M | +8.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.